Jason Westin

72PUBLICATIONS
301CO-AUTHORS
Cancer diagnosisChemotherapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (72)

|Jul 24, 2026
Clinical utility of real-time comprehensive molecular testing in large B-cell lymphoma.

|Jul 06, 2026
The Chaos of Choice in Large B-cell Lymphoma: A Call to Harmonize First-line Trial Design.

|Jul 02, 2026
Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma.

|Jun 24, 2026
A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell Lymphoma.

|Mar 31, 2026
Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis.

Nicolas Gower, Pierre Feugier, Jason R Westin

|Nov 18, 2025
Five-Year Analysis of the JULIET Trial of Tisagenlecleucel in Patients With Relapsed/Refractory Large B-Cell Lymphoma.

Richard T Maziarz, Michael R Bishop, Constantine S Tam

Pageof 12

Frequent Collaborators

20 joint publications

Sattva S Neelapu

14 joint publications

Sairah Ahmed

13 joint publications

Raphael Steiner

13 joint publications

Maria Rodriguez